Voltar
Artigo Revisado por pares
BIBTEX RIS

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

2024; Massachusetts Medical Society; Volume: 391; Issue: 2 Linguagem: Inglês

10.1056/nejmoa2403347

ISSN

1533-4406

Autores

Vlado Perkovic, Katherine R. Tuttle, Peter Rossing, Kenneth W. Mahaffey, Johannes F.E. Mann, George L. Bakris, Florian M.M. Baeres, Thomas Idorn, Heidrun Bosch‐Traberg, Nanna L. Lausvig, Richard Pratley,

Tópico(s)

Chronic Kidney Disease and Diabetes

Resumo

Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. Whether treatment with semaglutide would mitigate these risks is unknown.

Referência(s)